ClinicalTrials.gov
public full text
Public Domain
Oblimersen in Treating Patients With Merkel Cell Carcinoma
This phase II trial is studying how well oblimersen works in treating patients with Merkel cell cancer. Biological therapies, such as oblimersen, may interfere with the growth of tumor cells and slow the growth of Merkel cell carcinoma (skin cancer).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Docetaxel With or Without Oblimersen in Treating Patients With Non-Small Cell Lung Cancer#838975
- Oblimersen, Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma#1059879
- Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer#807790
- Radiotherapy for Merkel cell carcinoma: recommendations from the DEGRO Dermatooncology Working Group / Khaled Elsayad, Isabel Falke, Maike Trommer, Tina Jost, Alexander Rühle, ahmed gawish, Siyer Roohani, André Glowka, Markus Hecht, Eleni Gkika, Kathrin Hering, Laila König, Stefanie Corradini, Hans Theodor Eich, Dirk Vordermark#1078586
- Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer#871257
Record · ID 805971
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive